In Silico Design of Multimeric HN-F Antigen as a Highly Immunogenic Peptide Vaccine Against Newcastle Disease Virus
Application of molecular biology techniques to the production of new vaccines against different strains of the Newcastle disease virus (NDV) has been the subject of recent research reports. Development of improved techniques for genome sequencing has led to the recognition of protective mechanisms a...
Saved in:
Published in | International journal of peptide research and therapeutics Vol. 20; no. 2; pp. 179 - 194 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Netherlands
01.06.2014
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Application of molecular biology techniques to the production of new vaccines against different strains of the Newcastle disease virus (NDV) has been the subject of recent research reports. Development of improved techniques for genome sequencing has led to the recognition of protective mechanisms and the identification of possible candidate antigens. Such procedures could generate meaningful results regarding the virulence determinants of NDV. This study proposed an in silico approach by assembling potential and conserved epitopic regions of hemagglutinin–neuraminidase (HN) and fusion (F) glycoproteins of NDV to induce multiepitopic responses against the virus. Epitope predictions showed that the hypothetical synthetic construct could induce immature B and T cell epitopes that expect a high immune response because of their location in four distinct parts of the construct, namely the head, stalk and the heptad repeated regions known as the HRA and HRB domains. Most regions of the chimeric construct were found to have high antigenic propensity and surface accessibility, which further confirmed the strategy for selection of precise continuous and discontinuous epitopes of HN and F antigens. Thermodynamic folding of mRNA structures revealed correct folding of the RNA construct, indicating good stability of the mRNA to increase the efficiency of translation in the target host. The three-dimensional structure of the native HN-F chimeric protein was successfully generated and validated as a proper model which may define reliability, structural quality and conformation. |
---|---|
AbstractList | Application of molecular biology techniques to the production of new vaccines against different strains of the Newcastle disease virus (NDV) has been the subject of recent research reports. Development of improved techniques for genome sequencing has led to the recognition of protective mechanisms and the identification of possible candidate antigens. Such procedures could generate meaningful results regarding the virulence determinants of NDV. This study proposed an in silico approach by assembling potential and conserved epitopic regions of hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins of NDV to induce multiepitopic responses against the virus. Epitope predictions showed that the hypothetical synthetic construct could induce immature B and T cell epitopes that expect a high immune response because of their location in four distinct parts of the construct, namely the head, stalk and the heptad repeated regions known as the HRA and HRB domains. Most regions of the chimeric construct were found to have high antigenic propensity and surface accessibility, which further confirmed the strategy for selection of precise continuous and discontinuous epitopes of HN and F antigens. Thermodynamic folding of mRNA structures revealed correct folding of the RNA construct, indicating good stability of the mRNA to increase the efficiency of translation in the target host. The three-dimensional structure of the native HN-F chimeric protein was successfully generated and validated as a proper model which may define reliability, structural quality and conformation. Application of molecular biology techniques to the production of new vaccines against different strains of the Newcastle disease virus (NDV) has been the subject of recent research reports. Development of improved techniques for genome sequencing has led to the recognition of protective mechanisms and the identification of possible candidate antigens. Such procedures could generate meaningful results regarding the virulence determinants of NDV. This study proposed an in silico approach by assembling potential and conserved epitopic regions of hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins of NDV to induce multiepitopic responses against the virus. Epitope predictions showed that the hypothetical synthetic construct could induce immature B and T cell epitopes that expect a high immune response because of their location in four distinct parts of the construct, namely the head, stalk and the heptad repeated regions known as the HRA and HRB domains. Most regions of the chimeric construct were found to have high antigenic propensity and surface accessibility, which further confirmed the strategy for selection of precise continuous and discontinuous epitopes of HN and F antigens. Thermodynamic folding of mRNA structures revealed correct folding of the RNA construct, indicating good stability of the mRNA to increase the efficiency of translation in the target host. The three-dimensional structure of the native HN-F chimeric protein was successfully generated and validated as a proper model which may define reliability, structural quality and conformation.[PUBLICATION ABSTRACT] |
Author | Shahsavandi, Shahla Amani, Jafar Salmanian, Ali Hatef Motamedi, Mohammad Javad |
Author_xml | – sequence: 1 givenname: Mohammad Javad surname: Motamedi fullname: Motamedi, Mohammad Javad organization: Department of Plant Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB) – sequence: 2 givenname: Jafar surname: Amani fullname: Amani, Jafar organization: Applied Microbiology Research Center, Baqiyatallah Medical Science University – sequence: 3 givenname: Shahla surname: Shahsavandi fullname: Shahsavandi, Shahla organization: Razi Vaccine and Serum Research Institute – sequence: 4 givenname: Ali Hatef surname: Salmanian fullname: Salmanian, Ali Hatef email: salman@nigeb.ac.ir organization: Department of Plant Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB) |
BookMark | eNp9kd9rFDEQx4O0YFv9A3wL-OLLan7c7iaPR2u9g1oLrb6GXHaypuwmZyaL7X9vyilIQZ9mGD6fmYHvKTmKKQIhbzh7zxnrPyBnWumGcdloqVjz8IKc8LaXjdRsdfSn5yv9kpwi3jPWip6zE4LbSG_DFFyiF4BhjDR5-nmZSpghB0c3180lXccSRojUIrV0E8bv0yPdzvMSU51W6Ab2JQxAv1nnQgS6Hm2IWOg1_HQWywT0IiBYrETIC74ix95OCK9_1zPy9fLj3fmmufryaXu-vmqcXOnSDEMrexiU58POeZC9VLrvVdc58Nrtuta2QmghHFjugQvGOs1VK7wXfMe0lWfk3WHvPqcfC2Axc0AH02QjpAUNbwWTquNaVfTtM_Q-LTnW7yrFhRKStbxS_EC5nBAzeLPPYbb50XBmnmIwhxhMjcE8xWAeqtM_c1wotoQUS7Zh-q8pDibWK3GE_NdP_5R-AWeIni8 |
CitedBy_id | crossref_primary_10_1007_s11248_021_00295_2 crossref_primary_10_1007_s40203_024_00292_3 crossref_primary_10_1016_j_molliq_2020_113612 crossref_primary_10_3390_vaccines10030378 crossref_primary_10_1186_s43141_022_00357_w crossref_primary_10_3103_S0891416816030022 crossref_primary_10_1007_s12033_020_00254_y crossref_primary_10_3390_vaccines10081192 crossref_primary_10_1016_j_virusres_2019_197750 crossref_primary_10_1007_s10989_019_09952_x |
Cites_doi | 10.1128/CMR.00005-07 10.1016/S0167-7799(01)01670-5 10.1128/JVI.78.8.4176-4184.2004 10.1016/j.vaccine.2006.08.016 10.1093/protein/15.11.871 10.1186/1742-4682-6-28 10.1016/j.tibtech.2004.04.006 10.1093/nar/12.2.857 10.1016/S1386-6532(99)00072-4 10.1186/1471-2105-9-40 10.1093/protein/14.8.529 10.1002/prot.10286 10.1177/104063870802000402 10.1186/1297-9716-42-122 10.1016/j.vaccine.2009.09.095 10.1016/0022-2836(81)90003-6 10.1016/j.mimet.2012.04.001 10.1006/viro.1995.1497 10.1016/j.meegid.2009.09.012 10.1128/JVI.78.24.13727-13742.2004 10.1007/s00726-010-0830-x 10.1016/S1093-3263(00)00138-8 10.1111/j.1467-7652.2009.00497.x 10.1007/s00239-004-0277-3 10.1073/pnas.1111691108 10.1038/nbt0591-443 10.1007/s11250-010-9638-7 10.1007/s00299-011-1065-3 10.1007/s11095-006-9059-5 10.1016/0014-5793(90)80535-Q 10.1142/S0129183103005327 10.1007/s11095-008-9767-0 10.1016/j.sbi.2007.08.016 10.1099/0022-1317-70-11-3105 10.1038/35105075 10.1016/S1367-5931(00)00208-8 10.1021/bi00367a013 10.1586/erv.10.83 10.1155/2012/708216 10.1093/ps/82.6.899 10.1083/jcb.108.2.229 10.1016/S0097-8485(00)80008-X 10.1136/vr.140.1.20 10.1006/viro.2001.0899 10.1186/1471-2105-8-4 10.1093/bib/bbq008 10.4155/fmc.10.6 10.1016/0014-5793(90)80392-V 10.1016/j.ymeth.2004.06.004 10.1093/molbev/msl148 10.1093/nar/15.3.1281 10.2741/1187 10.1016/j.jchromb.2009.10.009 10.1038/nature04322 10.18553/jmcp.2007.13.s7-b.12 10.5772/26675 10.1016/j.vaccine.2005.01.059 10.1128/JVI.55.3.836-839.1985 10.1128/JVI.65.9.4999-5006.1991 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media New York 2013 Springer Science+Business Media New York 2014 |
Copyright_xml | – notice: Springer Science+Business Media New York 2013 – notice: Springer Science+Business Media New York 2014 |
DBID | AAYXX CITATION 3V. 7X7 7XB 88A 88I 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7T5 7U9 H94 |
DOI | 10.1007/s10989-013-9380-x |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central (New) (NC LIVE) ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) ProQuest One Academic (New) AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts ProQuest Central Student |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1573-3904 |
EndPage | 194 |
ExternalDocumentID | 3266930201 10_1007_s10989_013_9380_x |
Genre | Feature |
GroupedDBID | --- -56 -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 2.D 203 29J 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3V. 4.4 406 408 409 40E 53G 5GY 5VS 67N 67Z 6NX 7X7 88A 88I 8AO 8CJ 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDBF ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACGOD ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACUHS ACZOJ ADBBV ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFGCZ AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBNVY BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP D1J DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LK8 LLZTM M0L M2P M4Y M7P MA- NB0 NDZJH NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM OVD P19 PF0 PQQKQ PROAC PT4 PT5 Q2X QOR QOS R89 R9I RNS ROL RPX RSV S16 S1Z S26 S27 S28 S3A S3B SAP SBL SCLPG SDH SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZN T13 T16 TEORI TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z87 Z8O Z91 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT 7XB 8FK ABRTQ K9. PKEHL PQEST PQGLB PQUKI PRINS Q9U 7T5 7U9 H94 |
ID | FETCH-LOGICAL-c349t-dd537ed8f1dbcfe3738977866cef9cb65a522922cea1fe1200691852ff21b09a3 |
IEDL.DBID | U2A |
ISSN | 1573-3149 |
IngestDate | Fri Jul 11 03:46:09 EDT 2025 Fri Jul 25 19:17:09 EDT 2025 Tue Jul 01 02:21:32 EDT 2025 Thu Apr 24 23:07:36 EDT 2025 Fri Feb 21 02:26:12 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Epitope mapping Peptide vaccine Newcastle disease virus Codon optimization |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c349t-dd537ed8f1dbcfe3738977866cef9cb65a522922cea1fe1200691852ff21b09a3 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-2 content type line 23 |
PQID | 1512823051 |
PQPubID | 54427 |
PageCount | 16 |
ParticipantIDs | proquest_miscellaneous_1520386198 proquest_journals_1512823051 crossref_primary_10_1007_s10989_013_9380_x crossref_citationtrail_10_1007_s10989_013_9380_x springer_journals_10_1007_s10989_013_9380_x |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-06-01 |
PublicationDateYYYYMMDD | 2014-06-01 |
PublicationDate_xml | – month: 06 year: 2014 text: 2014-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht |
PublicationSubtitle | formerly known as "Letters in Peptide Science" |
PublicationTitle | International journal of peptide research and therapeutics |
PublicationTitleAbbrev | Int J Pept Res Ther |
PublicationYear | 2014 |
Publisher | Springer Netherlands Springer Nature B.V |
Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
References | Balen, Krsnik-Rasol (CR8) 2007; 45 Irving, Pan, Scott (CR31) 2001; 5 Iorio, Syddall, Sheehan, Bratt, Glickman, Riel (CR30) 1991; 65 Lamb, Kolakofsky, Knipe, Howley (CR38) 2001 Sinkovics, Horvath (CR53) 2000; 16 Susta, Miller, Afonso, Estevez, Yu, Zhang, Brown (CR56) 2010; 42 Lovell, Davis, Arendall, De Bakker, Word, Prisant, Richardson, Richardson (CR39) 2003; 50 Xiao, Huang, Xiao (CR61) 2003; 14 Soria-Guerra, Moreno-Fierros, Rosales-Mendoza (CR54) 2011; 30 Sharp, Li (CR52) 1987; 15 De Groot, Berzofsky (CR14) 2004; 34 Dunker, Lawson, Brown, Williams, Romero, Oh, Oldfield, Campen, Ratliff, Hipps, Ausio, Nissen, Reeves, Kang, Kissinger, Bailey, Griswold, Chiu, Garner, Obradovic (CR18) 2001; 19 Ikemura (CR29) 1981; 151 Henry, Sharp (CR25) 2007; 24 Amet, Lee, Shen (CR3) 2009; 26 Arai, Ueda, Kitayama, Kamiya, Nagamune (CR5) 2001; 14 Ryan, Daly, Mills (CR51) 2001; 19 Wang, Wu, Negre, White, Li, Shah (CR58) 2011; 12 Nazarian, Mousavi Gargari, Rasooli, Amani, Bagheri, Alerasool (CR45) 2012; 90 Wilkinson, Harrison (CR59) 1991; 9 Bai, Shen (CR7) 2006; 23 Yang, Liu, Pan, Yu, Jiao (CR62) 2007; 25 Earp, Delos, Park, White (CR19) 2005; 285 CR49 Gomord, Fitchette, Menu-Bouaouiche, Saint-Jore-Dupas, Plasson, Michaud, Faye (CR22) 2010; 8 Hines, Miller (CR26) 2012; 2012 De Groot, McMurry, Marcon, Franco, Rivera, Kutzler, Weiner, Martin (CR15) 2005; 23 Kukic, Nielsen (CR35) 2010; 2 CR46 Angenon, Van Montagu, Depicker (CR4) 1990; 271 Amani, Mousavi, Rafati, Salmanian (CR2) 2009; 6 Lakshmi, Subhashini (CR36) 2010; 2 Dortmans, Koch, Rottier, Peeters (CR16) 2011; 42 Huang, Elankumaran, Panda, Samal (CR27) 2003; 82 Huang, Panda, Elankumaran, Govindarajan, Rockemann, Samal (CR28) 2004; 78 Meeusen, Walker, Peters, Pastoret, Jungersen (CR42) 2007; 20 Lamb, Jardetzky (CR37) 2007; 17 McGinnes, Sergel, Reitter, Morrison (CR41) 2001; 283 Yin, Wen, Paterson, Lamb, Jardetzky (CR63) 2006; 439 Gustafsson, Govindarajan, Minshull (CR24) 2004; 22 Kozak (CR34) 1989; 108 Bashford (CR10) 2004; 9 Berzofsky, Ahlers, Belyakov (CR11) 2001; 1 Rosenberg (CR48) 2005 Gupta, Singh, Srivastava, Akhoon (CR23) 2009; 28 Kolaskar, Tongaonkar (CR32) 1990; 276 Parker, Guo, Hodges (CR47) 1986; 25 Alexander, Manvell, Frost, Pollitt, Welchman, Perry (CR1) 1997; 140 Doytchinova, Flower (CR17) 2007; 8 Wu, Fan, Li (CR60) 2009; 877 Yusoff, Nesbit, McCartney, Meulemans, Alexander, Collins, Emmerson, Samson (CR65) 1989; 70 Armstrong (CR6) 2007; 13 Chen, Zaro, Shen (CR13) 2012 Miller, Decanini, Afonso (CR44) 2010; 10 Sun, Chen, Xu, Luo (CR55) 2005; 61 George, Heringa (CR21) 2002; 15 Yuan, Swanson, Leser, Paterson, Lamb, Jardetzky (CR64) 2011; 108 Emini, Hughes, Perlow, Boger (CR20) 1985; 55 Bosch, Schots (CR12) 2010; 9 Baloria, Akhoon, Gupta, Sharma, Verma (CR9) 2012; 42 Mia Kim, Suarez, Afonso (CR43) 2008; 20 Wan, Wootton (CR57) 2000; 24 Zhang (CR66) 2008; 9 Russell, Jardetzky, Lamb (CR50) 2004; 78 Kozak (CR33) 1984; 12 McGinnes, Morrison (CR40) 1995; 212 DJ Alexander (9380_CR1) 1997; 140 9380_CR46 J Sun (9380_CR55) 2005; 61 M Kozak (9380_CR33) 1984; 12 L Susta (9380_CR56) 2010; 42 D Bosch (9380_CR12) 2010; 9 JG Sinkovics (9380_CR53) 2000; 16 SC Lovell (9380_CR39) 2003; 50 P Yuan (9380_CR64) 2011; 108 X Chen (9380_CR13) 2012 RA Lamb (9380_CR37) 2007; 17 LW McGinnes (9380_CR40) 1995; 212 IIM Rosenberg (9380_CR48) 2005 LW McGinnes (9380_CR41) 2001; 283 C Gustafsson (9380_CR24) 2004; 22 CJ Russell (9380_CR50) 2004; 78 DL Wilkinson (9380_CR59) 1991; 9 B Balen (9380_CR8) 2007; 45 PM Sharp (9380_CR52) 1987; 15 Y Zhang (9380_CR66) 2008; 9 AS Groot De (9380_CR15) 2005; 23 V Gomord (9380_CR22) 2010; 8 T Ikemura (9380_CR29) 1981; 151 J Amani (9380_CR2) 2009; 6 Z Huang (9380_CR28) 2004; 78 JM Parker (9380_CR47) 1986; 25 D Bashford (9380_CR10) 2004; 9 EN Meeusen (9380_CR42) 2007; 20 MB Irving (9380_CR31) 2001; 5 PTV Lakshmi (9380_CR36) 2010; 2 P Kukic (9380_CR35) 2010; 2 K Yusoff (9380_CR65) 1989; 70 AS Kolaskar (9380_CR32) 1990; 276 L Mia Kim (9380_CR43) 2008; 20 EJ Ryan (9380_CR51) 2001; 19 LJ Earp (9380_CR19) 2005; 285 JC Dortmans (9380_CR16) 2011; 42 EP Armstrong (9380_CR6) 2007; 13 PJ Miller (9380_CR44) 2010; 10 N Amet (9380_CR3) 2009; 26 R Arai (9380_CR5) 2001; 14 I Henry (9380_CR25) 2007; 24 YJ Wu (9380_CR60) 2009; 877 H Wan (9380_CR57) 2000; 24 G Angenon (9380_CR4) 1990; 271 Z Huang (9380_CR27) 2003; 82 RA Lamb (9380_CR38) 2001 NL Hines (9380_CR26) 2012; 2012 S Xiao (9380_CR61) 2003; 14 SK Gupta (9380_CR23) 2009; 28 IA Doytchinova (9380_CR17) 2007; 8 EA Emini (9380_CR20) 1985; 55 RE Soria-Guerra (9380_CR54) 2011; 30 ZQ Yang (9380_CR62) 2007; 25 AS Groot De (9380_CR14) 2004; 34 S Nazarian (9380_CR45) 2012; 90 HS Yin (9380_CR63) 2006; 439 Y Wang (9380_CR58) 2011; 12 JA Berzofsky (9380_CR11) 2001; 1 M Kozak (9380_CR34) 1989; 108 U Baloria (9380_CR9) 2012; 42 RM Iorio (9380_CR30) 1991; 65 RA George (9380_CR21) 2002; 15 9380_CR49 Y Bai (9380_CR7) 2006; 23 AK Dunker (9380_CR18) 2001; 19 |
References_xml | – volume: 20 start-page: 489 issue: 3 year: 2007 end-page: 510 ident: CR42 article-title: Current status of veterinary vaccines publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00005-07 – volume: 19 start-page: 293 issue: 8 year: 2001 end-page: 304 ident: CR51 article-title: Immunomodulators and delivery systems for vaccination by mucosal routes publication-title: Trends Biotechnol doi: 10.1016/S0167-7799(01)01670-5 – ident: CR49 – volume: 78 start-page: 4176 issue: 8 year: 2004 end-page: 4184 ident: CR28 article-title: The hemagglutinin–neuraminidase protein of Newcastle disease virus determines tropism and virulence publication-title: J Virol doi: 10.1128/JVI.78.8.4176-4184.2004 – volume: 25 start-page: 591 issue: 4 year: 2007 end-page: 598 ident: CR62 article-title: Expression of the fusion glycoprotein of Newcastle disease virus in transgenic rice and its immunogenicity in mice publication-title: Vaccine doi: 10.1016/j.vaccine.2006.08.016 – volume: 15 start-page: 871 issue: 11 year: 2002 end-page: 879 ident: CR21 article-title: An analysis of protein domain linkers: their classification and role in protein folding publication-title: Protein Eng doi: 10.1093/protein/15.11.871 – volume: 6 start-page: 28 year: 2009 ident: CR2 article-title: In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications publication-title: Theor Biol Med Model doi: 10.1186/1742-4682-6-28 – volume: 65 start-page: 4999 issue: 9 year: 1991 end-page: 5006 ident: CR30 article-title: Neutralization map of the hemagglutinin–neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition publication-title: J Virol – volume: 22 start-page: 346 issue: 7 year: 2004 end-page: 353 ident: CR24 article-title: Codon bias and heterologous protein expression publication-title: Trends Biotechnol doi: 10.1016/j.tibtech.2004.04.006 – volume: 12 start-page: 857 issue: 2 year: 1984 end-page: 872 ident: CR33 article-title: Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs publication-title: Nucleic Acids Res doi: 10.1093/nar/12.2.857 – volume: 16 start-page: 1 issue: 1 year: 2000 end-page: 15 ident: CR53 article-title: Newcastle disease virus (NDV): brief history of its oncolytic strains publication-title: J Clin Virol doi: 10.1016/S1386-6532(99)00072-4 – volume: 9 start-page: 40 year: 2008 ident: CR66 article-title: I-TASSER server for protein 3D structure prediction publication-title: BMC Bioinform doi: 10.1186/1471-2105-9-40 – volume: 14 start-page: 529 issue: 8 year: 2001 end-page: 532 ident: CR5 article-title: Design of the linkers which effectively separate domains of a bifunctional fusion protein publication-title: Protein Eng doi: 10.1093/protein/14.8.529 – volume: 50 start-page: 437 issue: 3 year: 2003 end-page: 450 ident: CR39 article-title: Structure validation by C-alpha geometry: phi, psi and C-beta deviation publication-title: Proteins doi: 10.1002/prot.10286 – volume: 20 start-page: 414 issue: 4 year: 2008 end-page: 425 ident: CR43 article-title: Detection of a broad range of class I and II Newcastle disease viruses using a multiplex real-time reverse transcription polymerase chain reaction assay publication-title: J Vet Diagn Invest doi: 10.1177/104063870802000402 – volume: 42 start-page: 122 issue: 1 year: 2011 ident: CR16 article-title: Virulence of newcastle disease virus: what is known so far? publication-title: Vet Res doi: 10.1186/1297-9716-42-122 – volume: 28 start-page: 120 issue: 1 year: 2009 end-page: 131 ident: CR23 article-title: In silico DNA vaccine designing against human papillomavirus (HPV) causing cervical cancer publication-title: Vaccine doi: 10.1016/j.vaccine.2009.09.095 – volume: 151 start-page: 389 year: 1981 end-page: 409 ident: CR29 article-title: Correlation between the abundance of transfer RNAs and the occurrence of the respective codons in its protein genes: a proposal for a synonymous codon choice that is optimal for the translational system publication-title: J Mol Biol doi: 10.1016/0022-2836(81)90003-6 – volume: 90 start-page: 36 year: 2012 end-page: 45 ident: CR45 article-title: An in silico chimeric multi subunit vaccine targeting virulence factors of enterotoxigenic (ETEC) with its bacterial inbuilt adjuvant publication-title: J Microbiol Met doi: 10.1016/j.mimet.2012.04.001 – volume: 212 start-page: 398 year: 1995 end-page: 410 ident: CR40 article-title: The role of individual oligosaccharide chains in activities of the HN glycoprotein of Newcastle disease virus publication-title: Virology doi: 10.1006/viro.1995.1497 – volume: 10 start-page: 26 issue: 1 year: 2010 end-page: 35 ident: CR44 article-title: Newcastle disease: evolution of genotypes and the related diagnostic challenges publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2009.09.012 – year: 2012 ident: CR13 article-title: Fusion protein linkers: property, design and functionality publication-title: Adv Drug Deliv Rev – volume: 78 start-page: 13727 issue: 24 year: 2004 end-page: 13742 ident: CR50 article-title: Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state publication-title: J Virol doi: 10.1128/JVI.78.24.13727-13742.2004 – volume: 42 start-page: 1349 issue: 4 year: 2012 end-page: 1360 ident: CR9 article-title: In silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancer publication-title: Amino Acids doi: 10.1007/s00726-010-0830-x – volume: 19 start-page: 26 issue: 1 year: 2001 end-page: 59 ident: CR18 article-title: Intrinsically disordered protein publication-title: J Mol Graph Model doi: 10.1016/S1093-3263(00)00138-8 – volume: 8 start-page: 564 issue: 5 year: 2010 end-page: 587 ident: CR22 article-title: Plant-specific glycosylation patterns in the context of therapeutic protein production publication-title: Plant Biotechnol J doi: 10.1111/j.1467-7652.2009.00497.x – ident: CR46 – volume: 61 start-page: 437 issue: 4 year: 2005 end-page: 444 ident: CR55 article-title: Relationships among stop codon usage bias, its context, isochores, and gene expression level in various eukaryotes publication-title: J Mol Evol doi: 10.1007/s00239-004-0277-3 – volume: 108 start-page: 14920 issue: 36 year: 2011 end-page: 14925 ident: CR64 article-title: Structure of the Newcastle disease virus hemagglutinin–neuraminidase (HN) ectodomain reveals a four-helix bundle stalk publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1111691108 – start-page: 1305 year: 2001 end-page: 1340 ident: CR38 article-title: Paramyxoviridae: the viruses and their replication publication-title: Fields virology – volume: 9 start-page: 443 issue: 5 year: 1991 end-page: 448 ident: CR59 article-title: Predicting the solubility of recombinant proteins in publication-title: Biotechnology doi: 10.1038/nbt0591-443 – volume: 2 start-page: 75 year: 2010 end-page: 84 ident: CR36 article-title: In silico sequence specific analysis of ERBB2 RTK alterations responsible for neuroectodermal tumors of Homo sapiens publication-title: J Bioinform Seq Anal – volume: 42 start-page: 1785 issue: 8 year: 2010 end-page: 1795 ident: CR56 article-title: Pathogenicity evaluation of different Newcastle disease virus chimeras in 4-week-old chickens publication-title: Trop Anim Health Prod doi: 10.1007/s11250-010-9638-7 – volume: 30 start-page: 1367 issue: 8 year: 2011 end-page: 1382 ident: CR54 article-title: Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches publication-title: Plant Cell Rep doi: 10.1007/s00299-011-1065-3 – volume: 23 start-page: 2116 issue: 9 year: 2006 end-page: 2121 ident: CR7 article-title: Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization publication-title: Pharm Res doi: 10.1007/s11095-006-9059-5 – volume: 276 start-page: 172 issue: 1–2 year: 1990 end-page: 174 ident: CR32 article-title: A semi-empirical method for prediction of antigenic determinants on protein antigens publication-title: FEBS Lett doi: 10.1016/0014-5793(90)80535-Q – volume: 14 start-page: 1191 year: 2003 end-page: 1199 ident: CR61 article-title: Local complexity of protein sequences publication-title: Int J Mod Phys C doi: 10.1142/S0129183103005327 – volume: 26 start-page: 523 issue: 3 year: 2009 end-page: 528 ident: CR3 article-title: Insertion of the designed helical linker led to increased expression of tf-based fusion proteins publication-title: Pharm Res doi: 10.1007/s11095-008-9767-0 – volume: 17 start-page: 427 issue: 4 year: 2007 end-page: 436 ident: CR37 article-title: Structural basis of viral invasion: lessons from paramyxovirus F publication-title: Curr Opin Struct Biol doi: 10.1016/j.sbi.2007.08.016 – volume: 70 start-page: 3105 year: 1989 end-page: 3109 ident: CR65 article-title: Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C publication-title: J Gen Virol doi: 10.1099/0022-1317-70-11-3105 – volume: 1 start-page: 209 issue: 3 year: 2001 end-page: 219 ident: CR11 article-title: Strategies for designing and optimizing new generation vaccines publication-title: Nat Rev Immunol doi: 10.1038/35105075 – volume: 5 start-page: 314 issue: 3 year: 2001 end-page: 324 ident: CR31 article-title: Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics publication-title: Curr Opin Chem Biol doi: 10.1016/S1367-5931(00)00208-8 – volume: 13 start-page: 12 year: 2007 end-page: 15 ident: CR6 article-title: Economic benefits and costs associated with target vaccinations publication-title: J Manag Care Pharm – volume: 25 start-page: 5425 issue: 19 year: 1986 end-page: 5432 ident: CR47 article-title: New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites publication-title: Biochemistry doi: 10.1021/bi00367a013 – volume: 9 start-page: 835 issue: 8 year: 2010 end-page: 842 ident: CR12 article-title: Plant glycans: friend or foe in vaccine development? publication-title: Expert Rev Vaccines doi: 10.1586/erv.10.83 – volume: 2012 start-page: 708216 year: 2012 ident: CR26 article-title: Avian paramyxovirus serotype-1: a review of disease distribution, clinical symptoms, and laboratory diagnostics publication-title: Vet Med Int doi: 10.1155/2012/708216 – volume: 45 start-page: 1 year: 2007 end-page: 10 ident: CR8 article-title: -glycosylation of recombinant therapeutic glycoproteins in plant systems publication-title: Food Technol Biotechnol – volume: 82 start-page: 899 issue: 6 year: 2003 end-page: 906 ident: CR27 article-title: Recombinant Newcastle disease virus as a vaccine vector publication-title: Poult Sci doi: 10.1093/ps/82.6.899 – volume: 108 start-page: 229 issue: 2 year: 1989 end-page: 241 ident: CR34 article-title: The scanning model for translation: an update publication-title: J Cell Biol doi: 10.1083/jcb.108.2.229 – volume: 24 start-page: 71 issue: 1 year: 2000 end-page: 94 ident: CR57 article-title: A global compositional complexity measure for biological sequences: AT-rich and GC-rich genomes encode less complex proteins publication-title: Comput Chem doi: 10.1016/S0097-8485(00)80008-X – volume: 140 start-page: 20 issue: 1 year: 1997 end-page: 22 ident: CR1 article-title: Newcastle disease outbreak in pheasants in Great Britain in May 1996 publication-title: Vet Rec doi: 10.1136/vr.140.1.20 – volume: 23 start-page: 2121 issue: 17–18 year: 2005 end-page: 2131 ident: CR15 article-title: Developing an epitope-driven tuberculosis (TB) vaccine publication-title: Vaccine – volume: 283 start-page: 332 year: 2001 end-page: 342 ident: CR41 article-title: Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity publication-title: Virology doi: 10.1006/viro.2001.0899 – volume: 8 start-page: 4 year: 2007 ident: CR17 article-title: VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines publication-title: BMC Bioinform doi: 10.1186/1471-2105-8-4 – volume: 12 start-page: 1 issue: 251 year: 2011 end-page: 13 ident: CR58 article-title: Determinants of antigenicity and specificity in immune response for protein sequences publication-title: BMC Bioinform doi: 10.1093/bib/bbq008 – year: 2005 ident: CR48 publication-title: Protein analysis and purification: Bench top techniques – volume: 2 start-page: 647 issue: 4 year: 2010 end-page: 666 ident: CR35 article-title: Electrostatics in proteins and protein-ligand complexes publication-title: Future Med Chem doi: 10.4155/fmc.10.6 – volume: 271 start-page: 144 year: 1990 end-page: 146 ident: CR4 article-title: Analysis of the stop codon context in plant nuclear genes publication-title: FEBS Lett doi: 10.1016/0014-5793(90)80392-V – volume: 34 start-page: 425 issue: 4 year: 2004 end-page: 428 ident: CR14 article-title: From genome to vaccine-new immunoinformatics tools for vaccine design publication-title: Methods doi: 10.1016/j.ymeth.2004.06.004 – volume: 55 start-page: 836 issue: 3 year: 1985 end-page: 839 ident: CR20 article-title: Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide publication-title: J Virol – volume: 24 start-page: 10 issue: 1 year: 2007 end-page: 12 ident: CR25 article-title: Predicting gene expression level from codon usage bias publication-title: Mol Biol Evol doi: 10.1093/molbev/msl148 – volume: 15 start-page: 1281 issue: 3 year: 1987 end-page: 1295 ident: CR52 article-title: The codon adaptation index–a measure of directional synonymous codon usage bias, and its potential applications publication-title: Nucleic Acids Res doi: 10.1093/nar/15.3.1281 – volume: 285 start-page: 25 year: 2005 end-page: 66 ident: CR19 article-title: The many mechanisms of viral membrane fusion proteins publication-title: Curr Top Microbiol Immunol – volume: 9 start-page: 1082 year: 2004 end-page: 1099 ident: CR10 article-title: Macroscopic electrostatic models for protonation states in proteins publication-title: Front Biosci doi: 10.2741/1187 – volume: 877 start-page: 4015 issue: 31 year: 2009 end-page: 4021 ident: CR60 article-title: Protein purification involving a unique auto-cleavage feature of a repeated EAAAK peptide publication-title: J Chromatogr B doi: 10.1016/j.jchromb.2009.10.009 – volume: 439 start-page: 38 year: 2006 end-page: 44 ident: CR63 article-title: Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation publication-title: Nature doi: 10.1038/nature04322 – volume: 17 start-page: 427 issue: 4 year: 2007 ident: 9380_CR37 publication-title: Curr Opin Struct Biol doi: 10.1016/j.sbi.2007.08.016 – volume-title: Protein analysis and purification: Bench top techniques year: 2005 ident: 9380_CR48 – volume: 14 start-page: 529 issue: 8 year: 2001 ident: 9380_CR5 publication-title: Protein Eng doi: 10.1093/protein/14.8.529 – volume: 13 start-page: 12 year: 2007 ident: 9380_CR6 publication-title: J Manag Care Pharm doi: 10.18553/jmcp.2007.13.s7-b.12 – volume: 108 start-page: 14920 issue: 36 year: 2011 ident: 9380_CR64 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1111691108 – volume: 212 start-page: 398 year: 1995 ident: 9380_CR40 publication-title: Virology doi: 10.1006/viro.1995.1497 – volume: 15 start-page: 1281 issue: 3 year: 1987 ident: 9380_CR52 publication-title: Nucleic Acids Res doi: 10.1093/nar/15.3.1281 – volume: 22 start-page: 346 issue: 7 year: 2004 ident: 9380_CR24 publication-title: Trends Biotechnol doi: 10.1016/j.tibtech.2004.04.006 – volume: 42 start-page: 1785 issue: 8 year: 2010 ident: 9380_CR56 publication-title: Trop Anim Health Prod doi: 10.1007/s11250-010-9638-7 – ident: 9380_CR46 doi: 10.5772/26675 – volume: 78 start-page: 4176 issue: 8 year: 2004 ident: 9380_CR28 publication-title: J Virol doi: 10.1128/JVI.78.8.4176-4184.2004 – volume: 15 start-page: 871 issue: 11 year: 2002 ident: 9380_CR21 publication-title: Protein Eng doi: 10.1093/protein/15.11.871 – start-page: 1305 volume-title: Fields virology year: 2001 ident: 9380_CR38 – volume: 42 start-page: 1349 issue: 4 year: 2012 ident: 9380_CR9 publication-title: Amino Acids doi: 10.1007/s00726-010-0830-x – volume: 20 start-page: 414 issue: 4 year: 2008 ident: 9380_CR43 publication-title: J Vet Diagn Invest doi: 10.1177/104063870802000402 – volume: 34 start-page: 425 issue: 4 year: 2004 ident: 9380_CR14 publication-title: Methods doi: 10.1016/j.ymeth.2004.06.004 – volume: 140 start-page: 20 issue: 1 year: 1997 ident: 9380_CR1 publication-title: Vet Rec doi: 10.1136/vr.140.1.20 – volume: 285 start-page: 25 year: 2005 ident: 9380_CR19 publication-title: Curr Top Microbiol Immunol – volume: 24 start-page: 10 issue: 1 year: 2007 ident: 9380_CR25 publication-title: Mol Biol Evol doi: 10.1093/molbev/msl148 – ident: 9380_CR49 – volume: 439 start-page: 38 year: 2006 ident: 9380_CR63 publication-title: Nature doi: 10.1038/nature04322 – volume: 8 start-page: 564 issue: 5 year: 2010 ident: 9380_CR22 publication-title: Plant Biotechnol J doi: 10.1111/j.1467-7652.2009.00497.x – volume: 271 start-page: 144 year: 1990 ident: 9380_CR4 publication-title: FEBS Lett doi: 10.1016/0014-5793(90)80392-V – volume: 12 start-page: 1 issue: 251 year: 2011 ident: 9380_CR58 publication-title: BMC Bioinform doi: 10.1093/bib/bbq008 – volume: 25 start-page: 5425 issue: 19 year: 1986 ident: 9380_CR47 publication-title: Biochemistry doi: 10.1021/bi00367a013 – volume: 16 start-page: 1 issue: 1 year: 2000 ident: 9380_CR53 publication-title: J Clin Virol doi: 10.1016/S1386-6532(99)00072-4 – volume: 6 start-page: 28 year: 2009 ident: 9380_CR2 publication-title: Theor Biol Med Model doi: 10.1186/1742-4682-6-28 – volume: 5 start-page: 314 issue: 3 year: 2001 ident: 9380_CR31 publication-title: Curr Opin Chem Biol doi: 10.1016/S1367-5931(00)00208-8 – volume: 8 start-page: 4 year: 2007 ident: 9380_CR17 publication-title: BMC Bioinform doi: 10.1186/1471-2105-8-4 – volume: 70 start-page: 3105 year: 1989 ident: 9380_CR65 publication-title: J Gen Virol doi: 10.1099/0022-1317-70-11-3105 – volume: 9 start-page: 40 year: 2008 ident: 9380_CR66 publication-title: BMC Bioinform doi: 10.1186/1471-2105-9-40 – volume: 24 start-page: 71 issue: 1 year: 2000 ident: 9380_CR57 publication-title: Comput Chem doi: 10.1016/S0097-8485(00)80008-X – volume: 25 start-page: 591 issue: 4 year: 2007 ident: 9380_CR62 publication-title: Vaccine doi: 10.1016/j.vaccine.2006.08.016 – volume: 1 start-page: 209 issue: 3 year: 2001 ident: 9380_CR11 publication-title: Nat Rev Immunol doi: 10.1038/35105075 – volume: 9 start-page: 443 issue: 5 year: 1991 ident: 9380_CR59 publication-title: Biotechnology doi: 10.1038/nbt0591-443 – volume: 23 start-page: 2121 issue: 17–18 year: 2005 ident: 9380_CR15 publication-title: Vaccine doi: 10.1016/j.vaccine.2005.01.059 – volume: 14 start-page: 1191 year: 2003 ident: 9380_CR61 publication-title: Int J Mod Phys C doi: 10.1142/S0129183103005327 – volume: 23 start-page: 2116 issue: 9 year: 2006 ident: 9380_CR7 publication-title: Pharm Res doi: 10.1007/s11095-006-9059-5 – volume: 2 start-page: 647 issue: 4 year: 2010 ident: 9380_CR35 publication-title: Future Med Chem doi: 10.4155/fmc.10.6 – volume: 10 start-page: 26 issue: 1 year: 2010 ident: 9380_CR44 publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2009.09.012 – volume: 82 start-page: 899 issue: 6 year: 2003 ident: 9380_CR27 publication-title: Poult Sci doi: 10.1093/ps/82.6.899 – volume: 2012 start-page: 708216 year: 2012 ident: 9380_CR26 publication-title: Vet Med Int doi: 10.1155/2012/708216 – volume: 2 start-page: 75 year: 2010 ident: 9380_CR36 publication-title: J Bioinform Seq Anal – volume: 45 start-page: 1 year: 2007 ident: 9380_CR8 publication-title: Food Technol Biotechnol – volume: 28 start-page: 120 issue: 1 year: 2009 ident: 9380_CR23 publication-title: Vaccine doi: 10.1016/j.vaccine.2009.09.095 – volume: 276 start-page: 172 issue: 1–2 year: 1990 ident: 9380_CR32 publication-title: FEBS Lett doi: 10.1016/0014-5793(90)80535-Q – volume: 108 start-page: 229 issue: 2 year: 1989 ident: 9380_CR34 publication-title: J Cell Biol doi: 10.1083/jcb.108.2.229 – volume: 78 start-page: 13727 issue: 24 year: 2004 ident: 9380_CR50 publication-title: J Virol doi: 10.1128/JVI.78.24.13727-13742.2004 – volume: 55 start-page: 836 issue: 3 year: 1985 ident: 9380_CR20 publication-title: J Virol doi: 10.1128/JVI.55.3.836-839.1985 – volume: 9 start-page: 835 issue: 8 year: 2010 ident: 9380_CR12 publication-title: Expert Rev Vaccines doi: 10.1586/erv.10.83 – year: 2012 ident: 9380_CR13 publication-title: Adv Drug Deliv Rev – volume: 9 start-page: 1082 year: 2004 ident: 9380_CR10 publication-title: Front Biosci doi: 10.2741/1187 – volume: 61 start-page: 437 issue: 4 year: 2005 ident: 9380_CR55 publication-title: J Mol Evol doi: 10.1007/s00239-004-0277-3 – volume: 877 start-page: 4015 issue: 31 year: 2009 ident: 9380_CR60 publication-title: J Chromatogr B doi: 10.1016/j.jchromb.2009.10.009 – volume: 26 start-page: 523 issue: 3 year: 2009 ident: 9380_CR3 publication-title: Pharm Res doi: 10.1007/s11095-008-9767-0 – volume: 65 start-page: 4999 issue: 9 year: 1991 ident: 9380_CR30 publication-title: J Virol doi: 10.1128/JVI.65.9.4999-5006.1991 – volume: 30 start-page: 1367 issue: 8 year: 2011 ident: 9380_CR54 publication-title: Plant Cell Rep doi: 10.1007/s00299-011-1065-3 – volume: 20 start-page: 489 issue: 3 year: 2007 ident: 9380_CR42 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00005-07 – volume: 12 start-page: 857 issue: 2 year: 1984 ident: 9380_CR33 publication-title: Nucleic Acids Res doi: 10.1093/nar/12.2.857 – volume: 50 start-page: 437 issue: 3 year: 2003 ident: 9380_CR39 publication-title: Proteins doi: 10.1002/prot.10286 – volume: 19 start-page: 293 issue: 8 year: 2001 ident: 9380_CR51 publication-title: Trends Biotechnol doi: 10.1016/S0167-7799(01)01670-5 – volume: 283 start-page: 332 year: 2001 ident: 9380_CR41 publication-title: Virology doi: 10.1006/viro.2001.0899 – volume: 90 start-page: 36 year: 2012 ident: 9380_CR45 publication-title: J Microbiol Met doi: 10.1016/j.mimet.2012.04.001 – volume: 19 start-page: 26 issue: 1 year: 2001 ident: 9380_CR18 publication-title: J Mol Graph Model doi: 10.1016/S1093-3263(00)00138-8 – volume: 151 start-page: 389 year: 1981 ident: 9380_CR29 publication-title: J Mol Biol doi: 10.1016/0022-2836(81)90003-6 – volume: 42 start-page: 122 issue: 1 year: 2011 ident: 9380_CR16 publication-title: Vet Res doi: 10.1186/1297-9716-42-122 |
SSID | ssj0052710 |
Score | 2.0357065 |
Snippet | Application of molecular biology techniques to the production of new vaccines against different strains of the Newcastle disease virus (NDV) has been the... |
SourceID | proquest crossref springer |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 179 |
SubjectTerms | Animal Anatomy Antigens Biochemistry Biomedical and Life Sciences Glycoproteins Histology Life Sciences Molecular biology Molecular Medicine Morphology Newcastle disease virus Peptides Pharmaceutical Sciences/Technology Pharmacology/Toxicology Polymer Sciences Viral infections |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB6a9NBcQl6lm0eZQOmhQcTyW6ewbLJsCl0KbcLejCxLYWFjJ_EuJP8-GtnebQPZqy1Z4E-PGX0z3wB8EzIIhfUcWGESzUKR2zWXiphJz2gqJ5LHTrvz1zge3YQ_J9GkvXCr27DKbk90G3VRKbojP6eTiUihiF88PDKqGkXsaltCYwM-knQZzepksnS4Ij9p1AiihHLIQtGxmk3qnAsW4gETQeqx5__PpZWx-YYfdcfOcAe2W3sR-w3Au_BBl3uw3y-tr3z_gt_RRXC6q_E9-DToqrftQ31d4p_pzOKMly5IAyuDLtvWUTQ4GrMh9ss5iXGirFEiRXzMXvCaEkYq-9Q2-k0hL4XGW6mIf8f-nZxacxLHVHWE-GG8bPgdvJ0-LeoDuBle_R2MWFtggSmL0JwVRRQkukgNL3JlNIkcCdKTi5U2QuVxJK11JnxfacmN5nT7ICjZ2hif556F-TNsllWpvwDaDonkQZRKySmZV6aRkoZrFSgZFLHqgdf93ky16uNUBGOWrXSTCZHMIpIRItlzD34suzw00hvrGh93mGXtKqyz1ZzpwenytQWCSBFZ6mpBbXwvSK0bmfbgrMP6n0-8N-Dh-gGPYMuaVmETVHYMm_OnhT6x5ss8_-rm6CsTHerp priority: 102 providerName: ProQuest |
Title | In Silico Design of Multimeric HN-F Antigen as a Highly Immunogenic Peptide Vaccine Against Newcastle Disease Virus |
URI | https://link.springer.com/article/10.1007/s10989-013-9380-x https://www.proquest.com/docview/1512823051 https://www.proquest.com/docview/1520386198 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1db9MwFL2C7QFeEGwgCqO6SIgHkKU4334MW0sHopqATuUpchwbVSopWlqJ_XvudZJtIEDiKVJy7Ug5sX3scz8AXigdxYp2DqJ2mRWxqmjM5SoVOnCWy4lUqc_d-WGezhbxu2Wy7OO428HbfZAk_Ux9I9jNu_fISKgoDwQRx_2Etu7sx7UIi2H6TcKsS0GQZBw4FqtByvxTF78uRtcM8zdR1K810_twryeJWHSoPoBbtjmAw6KhDfK3S3yJ3m3Tn4cfwJ3joWTbIbSnDX5arQlcPPGeGbhx6ENsvS6Ds7mYYtFsOQMn6hY1spvH-hJPOUpkQ3fJ6Iz9XGqL59qw6I7FV70iDolzLjXCojCedKIOnq8udu1DWEwnn49noq-qIAzBshV1nUSZrXMn68o4y5mNFCeRS411ylRpoomSqTA0VktnJR85KI6wdi6UVUDYPoK9ZtPYx4DUINMySnKtJUfw6jwx2klrIqOjOjUjCIbPW5o-5ThXvliX18mSGZGSECkZkfLHCF5dNfne5dv4l_HRgFnZD722ZArD6mEiR_D86jEBwUqIbuxmxzZhEOW0d8xH8HrA-kYXf3vhk_-yfgp3iV7FnWPZEextL3b2GVGYbTWG29kyG8N-8fbL-wld30zmZx_H_kf-CRvC7Ds |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VcigXBC2I0AKDBBxAK_y294BQ1BAltI2QaKvczHq9iyIFu20S0fwpfiMz6zgBJHrr1d6HvTO7M7PfPABeSRVGkiwHUdrUiEgWtOcymQjlWcPlRIrE5e48GSWDs-jzOB5vwa82FobdKtsz0R3UZa35jvw9SyYGhWL_48Wl4KpRjK62JTQatjgyy59kss0-DHtE39dB0P90ejgQq6oCQtNnzUVZxmFqysz6ZaGt4cw-kpOoJdpYqYskVqSSyCDQRvnW-GxyS44wtjbwC4_-jca9A3dJ8Hps7KXjtYEXB2mT_SBOOWYtki2K2oTqOeckPxQyzDxx_bcc3Ci3_-CxTsz1H8D9lX6K3YahHsKWqXZhr1uRbf5jiW_QeYy6q_hd2Dlsq8XtwWxY4dfJlPgKe84pBGuLLrrXQUI4GIk-dqs5J_9ENUOF7GEyXeKQA1RqekqNvrCLTWnwXGnG-7H7XU1IfcURVzlhPBp7DZ6E55OrxewRnN3K0j-G7aquzBNA6pAqP4wzpXwOHlZZrJX1jQ61CstEd8BrlzfXq2znXHRjmm_yNDNFcqJIzhTJrzvwdt3lokn1cVPjg5Zm-WrXz_INj3bg5fo1EYJBGFWZesFtAi_MyGzNOvCupfUfQ_xvwqc3T_gCdganJ8f58XB0tA_3SK2LGoe2A9ieXy3MM1Kd5sVzx68I3257g_wGqhMoGw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVAIuCFoQKQUGCTiArPpt7wGh0DRKKFgR0Ko3d73erSIFu9SJaP4av44ZPxpAorde7X3YO7M7M_vNA-ClkJ4vyHKwchNpyxcZ7blYhJa0jeZyIllY5-78nITjI__jSXCyAb-6WBh2q-zOxPqgzkvFd-R7LJkYFAqcPdO6RUyHo_fnPyyuIMVIa1dOo2GRQ736SeZb9W4yJFq_ct3Rwbf9sdVWGLAUfeLCyvPAi3QeGyfPlNGc5UdwQrVQaSNUFgaS1BPhukpLx2iHzW_B0cbGuE5m03_SuLdgM2KrqAebHw6S6ZdODgRu1ORCCCKOYPNFh6k2gXu1q5LjWcKLbevyb6m4VnX_QWdroTe6D_dabRUHDXs9gA1dbMH2oCBL_fsKX2PtP1pfzG_Bnf2udtw2VJMCv87mxGU4rF1EsDRYx_rWABGOE2uEg2LBqUBRViiR_U3mK5xwuEpJT6nRlB1uco3HUjH6j4MzOSNlFhOuecLoNA4bdAmPZxfL6iEc3cjiP4JeURb6MSB1iKTjBbGUDocSyzhQ0jhaeUp6eaj6YHfLm6o29zmX4Jin66zNTJGUKJIyRdLLPry56nLeJP64rvFuR7O0PQOqdM2xfXhx9ZoIwZCMLHS55Dau7cVkxMZ9eNvR-o8h_jfhzvUTPofbtDnST5Pk8AncJR3Pb7zbdqG3uFjqp6RHLbJnLcMinN70HvkNmZ8ttg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Silico+Design+of+Multimeric+HN-F+Antigen+as+a+Highly+Immunogenic+Peptide+Vaccine+Against+Newcastle+Disease+Virus&rft.jtitle=International+journal+of+peptide+research+and+therapeutics&rft.au=Motamedi%2C+Mohammad+Javad&rft.au=Amani%2C+Jafar&rft.au=Shahsavandi%2C+Shahla&rft.au=Salmanian%2C+Ali+Hatef&rft.date=2014-06-01&rft.pub=Springer+Netherlands&rft.issn=1573-3149&rft.eissn=1573-3904&rft.volume=20&rft.issue=2&rft.spage=179&rft.epage=194&rft_id=info:doi/10.1007%2Fs10989-013-9380-x&rft.externalDocID=10_1007_s10989_013_9380_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1573-3149&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1573-3149&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1573-3149&client=summon |